title: Pharmacological treatment options for autism spectrum disorders in children and adolescents.
abstract: Autism and other pervasive developmental disorders (PDDs) are frequently associated with dysfunctional behaviors and are characterized by deficits in socialization, communication, and behavioral rigidity. Despite the absence of a pharmacological cure for PDDs, many of the dysfunctional, coinciding behaviors may be treated pharmacologically. This article reviews what is known about the efficacy and tolerability of pharmacological interventions for the treatment of children and adolescents suffering from autistic spectrum disorders.
authors.affiliation: Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Leskovec
authors.forename: Brieana M
authors.initials: BM
authors.lastname: Rowles
authors.forename: Robert L
authors.initials: RL
authors.lastname: Findling
mesh_terms: D000293:Adolescent; D020817:Asperger Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D001321:Autistic Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D001521:Behavior Therapy; D002648:Child; D002653:Child Behavior Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D002659:Child Development Disorders, Pervasive / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003142:Communication; D018849:Controlled Clinical Trials as Topic; D006801:Humans; D007808:Language Therapy; D009788:Occupational Therapy; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012951:Socialization; D013070:Speech Therapy; D016896:Treatment Outcome
chemical_list: D011619:Psychotropic Drugs